1
|
Geretto P, Lombardo R, Albisinni S, Turchi B, Campi R, DE Cillis S, Vacca L, Pelizzari L, Gallo ML, Sampogna G, Giammo A, Li Marzi V, DE Nunzio C. Quality of information and appropriateness of ChatGPT outputs for neuro-urology. Minerva Urol Nephrol 2024; 76:138-140. [PMID: 38742548 DOI: 10.23736/s2724-6051.24.05807-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2024]
Affiliation(s)
- Paolo Geretto
- Unit of Neuro-Urology, Città della Salute e della Scienza University Hospital, University of Turin, Turin, Italy -
| | - Riccardo Lombardo
- Unit of Urology, Sant'Andrea Hospital, Sapienza University, Rome, Italy
| | - Simone Albisinni
- Unit of Urology, Department of Surgical Sciences, Tor Vergata University Hospital, Tor Vergata University of Rome, Rome, Italy
| | - Beatrice Turchi
- Unit of Urology, Sant'Andrea Hospital, Sapienza University, Rome, Italy
| | - Riccardo Campi
- Department of Minimally Invasive and Robotic Urologic Surgery, Careggi University Hospital, University of Florence, Florence, Italy
| | - Sabrina DE Cillis
- Division of Urology, Department of Oncology, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy
| | - Lorenzo Vacca
- Unit of Precision Gynecological Surgery, Dipartimento Centro di Eccellenza Donna e Bambino Nascente, Fatebenefratelli Gemelli Isola Tiberina, Rome, Italy
| | - Laura Pelizzari
- Department of Rehabilitative Medicine, AUSL Piacenza, Fiorenzuola d'Arda, Piacenza, Italy
| | - Maria L Gallo
- Department of Minimally Invasive and Robotic Urologic Surgery, Careggi University Hospital, University of Florence, Florence, Italy
| | - Gianluca Sampogna
- Unit of Urology, Niguarda Hospital, University of Milan, Milan, Italy
| | - Alessandro Giammo
- Unit of Neuro-Urology, Città della Salute e della Scienza University Hospital, University of Turin, Turin, Italy
| | - Vincenzo Li Marzi
- Department of Minimally Invasive and Robotic Urologic Surgery, Careggi University Hospital, University of Florence, Florence, Italy
| | - Cosimo DE Nunzio
- Unit of Urology, Sant'Andrea Hospital, Sapienza University, Rome, Italy
| |
Collapse
|
2
|
Esperto F, Testa A, Territo A, Faiella E, Papalia R, Scarpa RM. Applications of augmented reality in urology: expanding its potentials and fields of usage. Minerva Urol Nephrol 2024; 76:252-253. [PMID: 38742558 DOI: 10.23736/s2724-6051.24.05888-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/16/2024]
Affiliation(s)
| | - Antonio Testa
- Department of Urology, Campus Bio-Medico University, Rome, Italy
| | - Angelo Territo
- Department of Urology, Autonomous University of Barcelona, Barcelona, Spain
| | - Eliodoro Faiella
- Department of Radiology, Campus Bio-Medico University, Rome, Italy
| | - Rocco Papalia
- Department of Urology, Campus Bio-Medico University, Rome, Italy
| | - Roberto M Scarpa
- Department of Urology, Campus Bio-Medico University, Rome, Italy
| |
Collapse
|
3
|
Marmé F, Krieghoff-Henning E, Gerber B, Schmitt M, Zahm DM, Bauerschlag D, Forstbauer H, Hildebrandt G, Ataseven B, Brodkorb T, Denkert C, Stachs A, Krug D, Heil J, Golatta M, Kühn T, Nekljudova V, Gaiser T, Schönmehl R, Brochhausen C, Loibl S, Reimer T, Brinker TJ. Deep learning to predict breast cancer sentinel lymph node status on INSEMA histological images. Eur J Cancer 2023; 195:113390. [PMID: 37890350 DOI: 10.1016/j.ejca.2023.113390] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2023] [Revised: 10/07/2023] [Accepted: 10/11/2023] [Indexed: 10/29/2023]
Abstract
BACKGROUND Sentinel lymph node (SLN) status is a clinically important prognostic biomarker in breast cancer and is used to guide therapy, especially for hormone receptor-positive, HER2-negative cases. However, invasive lymph node staging is increasingly omitted before therapy, and studies such as the randomised Intergroup Sentinel Mamma (INSEMA) trial address the potential for further de-escalation of axillary surgery. Therefore, it would be helpful to accurately predict the pretherapeutic sentinel status using medical images. METHODS Using a ResNet 50 architecture pretrained on ImageNet and a previously successful strategy, we trained deep learning (DL)-based image analysis algorithms to predict sentinel status on hematoxylin/eosin-stained images of predominantly luminal, primary breast tumours from the INSEMA trial and three additional, independent cohorts (The Cancer Genome Atlas (TCGA) and cohorts from the University hospitals of Mannheim and Regensburg), and compared their performance with that of a logistic regression using clinical data only. Performance on an INSEMA hold-out set was investigated in a blinded manner. RESULTS None of the generated image analysis algorithms yielded significantly better than random areas under the receiver operating characteristic curves on the test sets, including the hold-out test set from INSEMA. In contrast, the logistic regression fitted on the Mannheim cohort retained a better than random performance on INSEMA and Regensburg. Including the image analysis model output in the logistic regression did not improve performance further on INSEMA. CONCLUSIONS Employing DL-based image analysis on histological slides, we could not predict SLN status for unseen cases in the INSEMA trial and other predominantly luminal cohorts.
Collapse
Affiliation(s)
- Frederik Marmé
- Department of Obstetrics and Gynaecology, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany
| | - Eva Krieghoff-Henning
- Digital Biomarkers for Oncology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | - Bernd Gerber
- Department of Obstetrics and Gynecology, University Hospital of Rostock, Rostock, Germany
| | - Max Schmitt
- Digital Biomarkers for Oncology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany
| | | | - Dirk Bauerschlag
- Department of Gynecology and Obstetrics, University Medical Center Schleswig-Holstein (UKSH), Campus Kiel, Kiel, Germany
| | | | - Guido Hildebrandt
- Department of Radiotherapy, University Medicine Rostock, Rostock, Germany
| | - Beyhan Ataseven
- Department of Gynecology, Gynecologic Oncology and Obstetrics, Klinikum Lippe, Bielefeld University, Medical School and University Medical Center East Westphalia-Lippe, Bielefeld, Germany
| | - Tobias Brodkorb
- Department of Obstetrics and Gynaecology, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany
| | - Carsten Denkert
- Institute of Pathology, University Clinic Marburg, Marburg, Germany
| | - Angrit Stachs
- Department of Obstetrics and Gynecology, University Hospital of Rostock, Rostock, Germany
| | - David Krug
- Klinik für Strahlentherapie, Universitätsklinikum Schleswig-Holstein, Kiel, Germany
| | - Jörg Heil
- Brustzentrum Heidelberg - Klinik St. Elisabeth, Heidelberg, Germany; Department of Obstetrics and Gynecology, Uniklinikum Heidelberg, Heidelberg, Germany
| | - Michael Golatta
- Brustzentrum Heidelberg - Klinik St. Elisabeth, Heidelberg, Germany; Department of Obstetrics and Gynecology, Uniklinikum Heidelberg, Heidelberg, Germany
| | - Thorsten Kühn
- Department of Gynaecology and Obstetrics, Klinikum Esslingen, Neckar, Germany
| | | | - Timo Gaiser
- Institute of Pathology, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany
| | - Rebecca Schönmehl
- Institute of Pathology, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany
| | - Christoph Brochhausen
- Institute of Pathology, Medical Faculty Mannheim of the University of Heidelberg, Heidelberg, Germany; Institute of Pathology, University Regensburg, Regensburg, Germany
| | - Sibylle Loibl
- German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany
| | - Toralf Reimer
- Department of Obstetrics and Gynecology, University Hospital of Rostock, Rostock, Germany
| | - Titus J Brinker
- Digital Biomarkers for Oncology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.
| |
Collapse
|
4
|
Puliatti S, Eissa A, Ferretti S, Micali S, Bianchi G. Fluorescence laser confocal microscopy: a glimpse from the future. Minerva Urol Nephrol 2023; 75:786-787. [PMID: 38126294 DOI: 10.23736/s2724-6051.23.05641-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2023]
Affiliation(s)
- Stefano Puliatti
- Department of Urology, University of Modena and Reggio Emilia, Modena, Italy -
| | - Ahmed Eissa
- Department of Urology, University of Modena and Reggio Emilia, Modena, Italy
- Department of Urology, Faculty of Medicine, University of Tanta, Tanta, Egypt
| | - Stefania Ferretti
- Department of Urology, University of Modena and Reggio Emilia, Modena, Italy
| | - Salvatore Micali
- Department of Urology, University of Modena and Reggio Emilia, Modena, Italy
| | - Giampaolo Bianchi
- Department of Urology, University of Modena and Reggio Emilia, Modena, Italy
| |
Collapse
|
5
|
Bianchi G, Puliatti S, Rodriguez Peñaranda N, Micali S, Bertoni L, Reggiani Bonetti L, Caramaschi S, Bolelli F, Pinamonti M, Rozze D, Grana C. Artificial intelligence evaluation of confocal microscope prostate images: our preliminary experience. Minerva Urol Nephrol 2023; 75:545-547. [PMID: 37728490 DOI: 10.23736/s2724-6051.23.05538-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/21/2023]
Affiliation(s)
- Giampaolo Bianchi
- Department of Urology, University of Modena and Reggio Emilia, Modena, Italy
| | - Stefano Puliatti
- Department of Urology, University of Modena and Reggio Emilia, Modena, Italy -
| | | | - Salvatore Micali
- Department of Urology, University of Modena and Reggio Emilia, Modena, Italy
| | - Laura Bertoni
- Department of Surgery, Medicine, Dentistry and Morphological Sciences with Interest in Transplant, Oncology and Regenerative Medicine, Modena, Italy
| | - Luca Reggiani Bonetti
- Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena Polyclinic Hospital, Modena, Italy
| | - Stefania Caramaschi
- Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena Polyclinic Hospital, Modena, Italy
| | - Federico Bolelli
- Enzo Ferrari Department of Engineering, University of Modena and Reggio Emilia, Modena, Italy
| | | | - Davide Rozze
- Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy
| | - Costantino Grana
- Enzo Ferrari Department of Engineering, University of Modena and Reggio Emilia, Modena, Italy
| |
Collapse
|
6
|
Yin LX, Rivera M, Garcia JJ, Bartemes KR, Lewis DB, Lohse CM, Routman DM, Ma DJ, Moore EJ, Van Abel KM. Impact of Tumor-Infiltrating Lymphocytes on Disease Progression in Human Papillomavirus-Related Oropharyngeal Carcinoma. Otolaryngol Head Neck Surg 2023; 169:539-547. [PMID: 36939471 DOI: 10.1002/ohn.249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2022] [Revised: 11/13/2022] [Accepted: 12/17/2022] [Indexed: 01/31/2023]
Abstract
OBJECTIVE We aim to explore the prognostic value of tumor-infiltrating lymphocytes (TILs) in the primary tumor and metastatic lymph nodes of patients with HPV(+)OPSCC. We hypothesize that TILS density at both sites is associated with disease-free survival in HPV(+)OPSCC. STUDY DESIGN Matched case-control study among HPV(+)OPSCC patients who underwent intent-to-cure surgery. Cases developed locoregional or distant recurrence. Controls were matched based on age, sex, pathologic T, N, and overall stage, year of surgery, type of adjuvant treatment received, and the Adult Comorbidity Evaluation-27 (ACE-27) score. SETTING Single tertiary care center, May 2007 to December 2016. METHODS Tumoral TILs (tTILs) density was defined as % TILs; stromal TILs (sTILs) density was defined as absent/sparse or moderate/dense crowding. Associations between TILs and time to disease progression were assessed using Cox regression models. RESULTS Forty-four case-control pairs (N = 88) were included: 42 (48%) AJCC pStage I, 39 (44%) pStage II, and 7 (8%) pStage III. tTILs density ≥10% (hazard ratio [HR] 0.41, 95% confidence interval [CI] 0.17-0.99, p = .048) and a moderate/dense sTILs density (HR 0.21, 95% CI 0.06-0.75, p = .016) in the primary tumor were significantly associated with decreased risk of progression. TILs density in the lymph node was associated with decreased risk of progression but did not reach statistical significance. The tTILs and sTILs density correlated strongly between the primary tumor and lymph node. Concordance between the pathologists' was moderate (60%-70%). CONCLUSIONS In HPV(+)OPSCC, a higher density of tumoral and stromal TILs in the primary tumor and possibly the lymph node may predict a lower risk of disease progression.
Collapse
Affiliation(s)
- Linda X Yin
- Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA
| | - Michael Rivera
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
| | - Joaquin J Garcia
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA
| | - Kathleen R Bartemes
- Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA
| | - Derrick B Lewis
- Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA
| | - Christine M Lohse
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA
| | - David M Routman
- Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA
| | - Daniel J Ma
- Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA
| | - Eric J Moore
- Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA
| | - Kathryn M Van Abel
- Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA
| |
Collapse
|
7
|
Ren H, Ren C, Guo Z, Zhang G, Luo X, Ren Z, Tian H, Li W, Yuan H, Hao L, Wang J, Zhang M. A novel approach for automatic segmentation of prostate and its lesion regions on magnetic resonance imaging. Front Oncol 2023; 13:1095353. [PMID: 37152013 PMCID: PMC10154598 DOI: 10.3389/fonc.2023.1095353] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2022] [Accepted: 03/30/2023] [Indexed: 05/09/2023] Open
Abstract
Objective To develop an accurate and automatic segmentation model based on convolution neural network to segment the prostate and its lesion regions. Methods Of all 180 subjects, 122 healthy individuals and 58 patients with prostate cancer were included. For each subject, all slices of the prostate were comprised in the DWIs. A novel DCNN is proposed to automatically segment the prostate and its lesion regions. This model is inspired by the U-Net model with the encoding-decoding path as the backbone, importing dense block, attention mechanism techniques, and group norm-Atrous Spatial Pyramidal Pooling. Data augmentation was used to avoid overfitting in training. In the experimental phase, the data set was randomly divided into a training (70%), testing set (30%). four-fold cross-validation methods were used to obtain results for each metric. Results The proposed model achieved in terms of Iou, Dice score, accuracy, sensitivity, 95% Hausdorff Distance, 86.82%,93.90%, 94.11%, 93.8%,7.84 for the prostate, 79.2%, 89.51%, 88.43%,89.31%,8.39 for lesion region in segmentation. Compared to the state-of-the-art models, FCN, U-Net, U-Net++, and ResU-Net, the segmentation model achieved more promising results. Conclusion The proposed model yielded excellent performance in accurate and automatic segmentation of the prostate and lesion regions, revealing that the novel deep convolutional neural network could be used in clinical disease treatment and diagnosis.
Collapse
Affiliation(s)
- Huipeng Ren
- Department of Medical Imaging, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
- Department of Medical Imaging, Baoji Central Hospital, Baoji, China
| | - Chengjuan Ren
- Department of Language Intelligence, Sichuan International Studies University, Chongqing, China
| | - Ziyu Guo
- Department of Computer Science & Engineering, The Chinese University of Hong Kong, Hong Kong, Hong Kong SAR, China
| | - Guangnan Zhang
- Department of Computer Science, Baoji University of Arts and Sciences, Baoji, China
| | - Xiaohui Luo
- Department of Urology, Baoji Central Hospital, Baoji, China
| | - Zhuanqin Ren
- Department of Medical Imaging, Baoji Central Hospital, Baoji, China
| | - Hongzhe Tian
- Department of Medical Imaging, Baoji Central Hospital, Baoji, China
| | - Wei Li
- Department of Medical Imaging, Baoji Central Hospital, Baoji, China
| | - Hao Yuan
- Department of Computer Science, Baoji University of Arts and Sciences, Baoji, China
| | - Lele Hao
- Department of Computer Science, Baoji University of Arts and Sciences, Baoji, China
| | - Jiacheng Wang
- Department of Computer Science, Baoji University of Arts and Sciences, Baoji, China
| | - Ming Zhang
- Department of Medical Imaging, First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
- *Correspondence: Ming Zhang,
| |
Collapse
|
8
|
Rivero Belenchón I, Checcucci E, Gómez Rivas J, Puliatti S, Taratkin M, Kowalewski KF, Rodler S, Veccia A, Medina Lopez RA, Cacciamani G. Comment on "Artificial intelligence to predict oncological outcome directly from hematoxylin and eosin-stained slides in urology: a systematic review". Minerva Urol Nephrol 2022; 74:810-812. [PMID: 36629813 DOI: 10.23736/s2724-6051.22.05180-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Affiliation(s)
- Inés Rivero Belenchón
- Department of Urology and Nephrology, Biomedical Institute of Seville (IBiS), Virgen del Rocío University Hospital, University of Seville, Seville, Spain - .,Young Academic Urologist-Urotechnology Working Party (ESUT-YAU), European Association of Urology, Arnhem, the Neatherlands -
| | - Enrico Checcucci
- Young Academic Urologist-Urotechnology Working Party (ESUT-YAU), European Association of Urology, Arnhem, the Neatherlands.,Division of Urology, Department of Surgery, IRCC Candiolo Cancer Institute, Candiolo, Turin, Italy
| | - Juan Gómez Rivas
- Young Academic Urologist-Urotechnology Working Party (ESUT-YAU), European Association of Urology, Arnhem, the Neatherlands.,Department of Urology, San Carlos Hospital, Madrid, Spain
| | - Stefano Puliatti
- Young Academic Urologist-Urotechnology Working Party (ESUT-YAU), European Association of Urology, Arnhem, the Neatherlands.,Department of Urology, University of Modena and Reggio Emilia, Modena, Italy
| | - Mark Taratkin
- Young Academic Urologist-Urotechnology Working Party (ESUT-YAU), European Association of Urology, Arnhem, the Neatherlands.,Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia
| | - Karl-Friedrich Kowalewski
- Young Academic Urologist-Urotechnology Working Party (ESUT-YAU), European Association of Urology, Arnhem, the Neatherlands.,Department of Urology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
| | - Severin Rodler
- Young Academic Urologist-Urotechnology Working Party (ESUT-YAU), European Association of Urology, Arnhem, the Neatherlands.,Department of Urology, Klinikum der Univertität München, Munich, Germany
| | - Alessandro Veccia
- Young Academic Urologist-Urotechnology Working Party (ESUT-YAU), European Association of Urology, Arnhem, the Neatherlands.,Unit of Urology, AOUI Verona, Verona, Italy
| | - Rafael A Medina Lopez
- Department of Urology and Nephrology, Biomedical Institute of Seville (IBiS), Virgen del Rocío University Hospital, University of Seville, Seville, Spain
| | - Giovanni Cacciamani
- Young Academic Urologist-Urotechnology Working Party (ESUT-YAU), European Association of Urology, Arnhem, the Neatherlands.,Catherine and Joseph Aresty Department of Urology, US Institute of Urology, University of Southern California, Los Angeles, CA, USA
| | | |
Collapse
|
9
|
Muselaers S, Amparore D, Bertolo R, Diana P, Erdem S, Marandino L, Carbonara U, Borregales LD, Pavan N, Pecoraro A, Roussel E, Pecoraro A, Campi R, Marchioni M. Optimizing postoperative follow-up in RCC patients: why does it always have to be black and white? Minerva Urol Nephrol 2022; 74:822-824. [PMID: 36629817 DOI: 10.23736/s2724-6051.22.05211-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Affiliation(s)
- Stijn Muselaers
- Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands -
| | - Daniele Amparore
- Division of Urology, Department of Oncology, School of Medicine, San Luigi Gonzaga Hospital, University of Turin, Orbassano, Turin, Italy
| | | | - Pietro Diana
- Department of Urology, Humanitas Clinical and Research Institute IRCCS, Rozzano, Milan, Italy
| | - Selçuk Erdem
- Division of Urologic Oncology, Department of Urology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
| | - Laura Marandino
- Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy
| | - Umberto Carbonara
- Unit of Andrology and Kidney Transplantation, Department of Emergency and Organ Transplantation-Urology, University of Bari, Bari, Italy
| | - Leonardo D Borregales
- Department of Urology, Weill Cornell Medicine/New York-Presbyterian, New York, NY, USA
| | - Nicola Pavan
- Unit of Urology, Department of Surgical, Oncological and Oral Sciences, P. Giaccone University Hospital, Palermo, Italy
| | - Angela Pecoraro
- Division of Urology, Pederzoli Hospital, Peschiera del Garda, Verona, Italy
| | - Eduard Roussel
- Department of Urology, University Hospitals of Leuven, Leuven, Belgium
| | - Alessio Pecoraro
- Department of Medical, Oral and Biotechnological Sciences, Laboratory of Biostatistics, G. D'Annunzio Chieti-Pescara University, Chieti, Italy
| | - Riccardo Campi
- Unit of Urological Robotic Surgery and Renal Transplantation, Careggi Hospital, University of Florence, Florence, Italy.,Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
| | - Michele Marchioni
- Department of Medical, Oral and Biotechnological Sciences, Laboratory of Biostatistics, G. D'Annunzio Chieti-Pescara University, Chieti, Italy.,Department of Urology, SS Annunziata Hospital, G. D'Annunzio Chieti-Pescara University, Chieti, Italy
| |
Collapse
|
10
|
Fiori C, Porpiglia F. Renal cancer: From current evidences to future perspectives. Asian J Urol 2022; 9:199-200. [PMID: 36035348 PMCID: PMC9399550 DOI: 10.1016/j.ajur.2022.05.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2022] [Accepted: 05/18/2022] [Indexed: 11/29/2022] Open
|